Network model‐based screen for FDA‐approved drugs affecting cardiac fibrosis

Cardiac fibrosis is a significant component of pathological heart remodeling, yet it is not directly targeted by existing drugs. Systems pharmacology approaches have the potential to provide mechanistic frameworks with which to predict and understand how drugs modulate biological systems. Here, we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeigler, Angela C., Chandrabhatla, Anirudha S., Christiansen, Steven L., Nelson, Anders R., Holmes, Jeffrey W., Saucerman, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099443/
https://www.ncbi.nlm.nih.gov/pubmed/33571402
http://dx.doi.org/10.1002/psp4.12599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099443/
https://www.ncbi.nlm.nih.gov/pubmed/33571402
http://dx.doi.org/10.1002/psp4.12599

Ejemplares similares